208 related articles for article (PubMed ID: 31389495)
1. Difficulties in activities of daily living are associated with stigma in patients with Parkinson's disease who are candidates for deep brain stimulation.
da Silva AG; Leal VP; da Silva PR; Freitas FC; Linhares MN; Walz R; Malloy-Diniz LF; Diaz AP; Palha AP
Braz J Psychiatry; 2020 Apr; 42(2):190-194. PubMed ID: 31389495
[TBL] [Abstract][Full Text] [Related]
2. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
[TBL] [Abstract][Full Text] [Related]
3. Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.
Dafsari HS; Reker P; Stalinski L; Silverdale M; Rizos A; Ashkan K; Barbe MT; Fink GR; Evans J; Steffen J; Samuel M; Dembek TA; Visser-Vandewalle V; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Timmermann L;
Mov Disord; 2018 Jan; 33(1):99-107. PubMed ID: 29150860
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
[TBL] [Abstract][Full Text] [Related]
5. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
[TBL] [Abstract][Full Text] [Related]
6. Variables associated with physical health-related quality of life in Parkinson's disease patients presenting for deep brain stimulation.
Diaz AP; Freitas FC; de Oliveira Thais ME; da Silva Areas FZ; Schwarzbold ML; Debona R; Nunes JC; Guarnieri R; Martinez-Ramirez D; Prediger RD; Wagle Shukla A; Linhares MN; Walz R
Neurol Sci; 2016 Nov; 37(11):1831-1837. PubMed ID: 27457654
[TBL] [Abstract][Full Text] [Related]
7. Effects of bilateral stimulation of the subthalamic nucleus in Parkinson's disease with and without REM sleep behaviour disorder.
Bargiotas P; Debove I; Bargiotas I; Lachenmayer ML; Ntafouli M; Vayatis N; Schüpbach MW; Krack P; Bassetti CL
J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1310-1316. PubMed ID: 31422368
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
9. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.
Dafsari HS; Petry-Schmelzer JN; Ray-Chaudhuri K; Ashkan K; Weis L; Dembek TA; Samuel M; Rizos A; Silverdale M; Barbe MT; Fink GR; Evans J; Martinez-Martin P; Antonini A; Visser-Vandewalle V; Timmermann L; ;
Brain Stimul; 2018; 11(4):904-912. PubMed ID: 29655586
[TBL] [Abstract][Full Text] [Related]
10. Activities of Daily Living and Their Relationship to Health-Related Quality of Life in Patients with Parkinson Disease After Subthalamic Nucleus Deep Brain Stimulation.
Gorecka-Mazur A; Furgala A; Krygowska-Wajs A; Pietraszko W; Kwinta B; Gil K
World Neurosurg; 2019 May; 125():e552-e562. PubMed ID: 30716489
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
[TBL] [Abstract][Full Text] [Related]
12. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
Santos-García D; de la Fuente-Fernández R
J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.
Hariz GM; Limousin P; Zrinzo L; Tripoliti E; Aviles-Olmos I; Jahanshahi M; Hamberg K; Foltynie T
Acta Neurol Scand; 2013 Oct; 128(4):281-5. PubMed ID: 23550919
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
16. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; Alvarez-Sánchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martínez-Castrillo JC; Mendoza-Rodríguez A; Moore HP; Rodríguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2014 Mar; 21(3):519-24. PubMed ID: 24447695
[TBL] [Abstract][Full Text] [Related]
18. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
[TBL] [Abstract][Full Text] [Related]
19. Predictors of self-perceived stigma in Parkinson's disease.
Salazar RD; Weizenbaum E; Ellis TD; Earhart GM; Ford MP; Dibble LE; Cronin-Golomb A
Parkinsonism Relat Disord; 2019 Mar; 60():76-80. PubMed ID: 30297211
[TBL] [Abstract][Full Text] [Related]
20. Depression, quality of life, activities of daily living, and subjective memory after deep brain stimulation in Parkinson disease-A reliable change index analysis.
Pusswald G; Wiesbauer P; Pirker W; Novak K; Foki T; Lehrner J
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1698-1705. PubMed ID: 31368144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
